Maisons-Alfort, France

Imane Boucenna

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Assistance Publique-Hopitaux De Paris. Active years: 2018.


% Patents Active = 100.0


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Imane Boucenna: Innovator in Gelling Formulations

Introduction

Imane Boucenna is a notable inventor based in Maisons-Alfort, France. She has made significant contributions to the field of medical treatments, particularly in the formulation of gelling agents. Her innovative work focuses on improving the treatment of hydrofluoric acid burns.

Latest Patents

Imane Boucenna holds a patent for a gelling formulation based on calcium gluconate. This invention involves a gelling formulation that includes calcium gluconate in a water solution combined with a poloxamer. The formulation is specifically designed for use in treating hydrofluoric acid burns, showcasing her commitment to advancing medical treatments.

Career Highlights

Imane Boucenna is affiliated with Assistance Publique-Hôpitaux de Paris, where she continues to contribute to research and development in her field. Her work is characterized by a focus on practical applications that can significantly impact patient care.

Collaborations

Imane collaborates with esteemed colleagues, including Marie-Caroline Husson and Pierre Colinart. These partnerships enhance her research efforts and contribute to the advancement of innovative medical solutions.

Conclusion

Imane Boucenna's work in developing gelling formulations represents a significant advancement in the treatment of chemical burns. Her dedication to innovation and collaboration in the medical field is commendable and highlights the importance of research in improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…